Anterior Temporal Epilepsy Neuropsychological Assessment of Faces
NCT ID: NCT02888925
Last Updated: 2019-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2013-08-31
2020-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Secondary purposes are to prospectively evaluate neuropsychological impact of anterior temporal lobectomy performed for surgical treatment of anterior temporal epilepsy on face perception (exploratory study).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Single Neurons Responses During Visual Recognition in Epileptic Patients
NCT02877576
Cartography of Functional and Epileptic Cerebral Areas by Functional MRI and Electroencephalography in Epileptic Patients Before and After Surgery
NCT03102957
Pre-operative Mapping of the Anterior Temporal Lobe Using Functional MRI Innovative Techniques in in Drug-resistant Epileptic Patients
NCT05339438
Capturing Autobiographical Memory Formation in Real World Spaces Using Multimodal Recordings
NCT06883981
Episodic Memory Before and After Surgery in Drug-resistant Partial Epilepsies
NCT01919957
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Epilepsy
Patients do face specific tests during conventional pre-lobectomy intercritical assessment hospitalization (inclusion, day 0) and after 6 and 18 months from anterior temporal lobectomy
Mooney test
Benton Face Recognition test
Face inversion effect test
Face composite effect test
Cambridge Face Memory Test
Matching different view test
Memorizing and recognition of new faces test
Memorizing and recognition of new objects test
Recognition of celebrities and access to semantic information test
Lobectomy
In patients with anterior temporal epilepsy, at 6 to 12 months after inclusion, depending on surgery decision taken after pre-surgery conventional intercritical assessment
Control
Control individuals do face specific tests during inclusion visit (day 0) and after X months (X = time from day 0 and lobectomy of matched patient + 6 months)
Mooney test
Benton Face Recognition test
Face inversion effect test
Face composite effect test
Cambridge Face Memory Test
Matching different view test
Memorizing and recognition of new faces test
Memorizing and recognition of new objects test
Recognition of celebrities and access to semantic information test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mooney test
Benton Face Recognition test
Face inversion effect test
Face composite effect test
Cambridge Face Memory Test
Matching different view test
Memorizing and recognition of new faces test
Memorizing and recognition of new objects test
Recognition of celebrities and access to semantic information test
Lobectomy
In patients with anterior temporal epilepsy, at 6 to 12 months after inclusion, depending on surgery decision taken after pre-surgery conventional intercritical assessment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent
* Affiliation to social security
* Preliminary medical examination
PATIENTS WITH EPILEPSY:
* Symptomatic drug-resistant anterior temporal epilepsy (confirmed with video-electroencephalography and magnetic resonance imaging and if necessary intracerebral SEEG exploration)
* Patient needing anterior temporal lobectomy and undergoing pre-surgery conventional intercritical assessment for surgery decision
* Nonverbal IQ ≥ 70 (WAIS-IV)
* At least 6 successful VOSP tests (perception test)
Exclusion Criteria
* persons under legal protection or incapable to consent
* Persons deprived of liberty by juridical or administrative decision
PATIENTS WITH EPILEPSY:
\- Sever visual disorders of neurological or ophthalmological origin
CONTROL INDIVIDUALS:
* Psychiatric or neurological disorders
* Important ophthalmological disorders
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Louis Maillard
Role: PRINCIPAL_INVESTIGATOR
Service de Neurologie, Hôpital Central, CHU de Nancy, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Neurologie, Hôpital Central, CHU de Nancy
Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-A00515-40
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.